Papillon Patients in Phase III Opera Trial

The Phase III trial called OPERA which started in France at the end of 2015 has now passed Ethics here in the UK.

Read more

NICE ratify Papillon therapy for rectal cancer

NICE ratify X-ray brachytherapy for Rectal Cancer treatment.

The National Institute of Health & Care Excellence (NICE) have finished their consultation period for the use of Papillon X-Ray Brachytherapy for the treatment of rectal cancer and published their recommendations.

Read more

Centre Antoine-Lacassagne (Nice – France) order the first Papillon+ X-Ray Brachytherapy System

Prof Gerard, of the Centre Antoine-Lacassagne in Nice, has ordered the first Papillon+ X-Ray Brachytherapy System for the use in treating breast cancer with an IORT boost.

Read more

SCM Société Oncologie Radiotherapie (MÂCON – France) order Papillion+ X-Ray Brachytherapy System

Dr. Nicolas Barbet, of the Société Oncologie Radiotherapie in MÂCON, is the second clinician in France to place an order for the new Papillon+ X-Ray Brachy.

Read more

Clinique Generale Beaulieu (Geneva) Order Switzerland’s first Papillon+ for IORT Breast treatment

Ariane Medical Systems Ltd are very proud to announce the Clinique Generale Beaulieu, part of the Swiss Medical Network, have placed an order for the Papillon+ X-Ray Brachytherapy System for the use of delivering an IORT radiation boost for breast cancer patients.

Read more

Phase III Clinical Trial OPERA starts

The Organ Preservation of Early Rectal Adenocarcinoma (OPERA) phase III trial has started to recruit patients at the Centre Antoine-Lacassagne in Nice, France. This Pan-European trial, developed by Prof Jean-Pierre Gerard (Nice) and Prof Arthur Sun Myint (Clatterbridge, UK) is looking to recruit patients across existing Papillon users in France, UK, Sweden, Denmark and Switzerland as well as driving interest in new territories.

Read more